Good Lifestyle

Months after the beginning of its beginning, the deployment of Covid-19 vaccines in the United States shows panels that the very effective immunizations used contribute to reducing theNational infection rate. But very contagious variants of the virus that emerged at the time of the Vaccines de la Moderna and Pfizer-Biontech continued to concern certain health officials they might perhaps escape the effectiveness of fire. Fortunately, a pair of new studies has shown that the Pfizer vaccine is always very effective in protecting two of the worst variants currently circulating. Read it to see what researchers have found and for more information on how other shots,That's how much the moderna vaccine really protects you, a new study says.

According to two distinct real studies conducted in Israel and Qatar, thePfizer Covid-19 vaccine Is very effective against two of the most important variants: B.1.1.7, which was detected for the first time in U.K., And B.1.351, which is from South Africa. The results are scientists and pharmaceutical companies try to gauge how muchExisting vaccines Work against very contagious strains.

"That's very good news,"Annelies Wilder-Smith, MD, an infectious researcher of London School of Hygiene and tropical medicine disease, saidThe New York Times. "At that time, we can say with confidence that we can use this vaccine, even in the presence of variants of concern in circulation."

The first study, which was published in a letter to theNew England Journal of Medicine, analyzed the data from the Qatar COVID-19 database including information on more than 200,000 people over 200,000 people from February and March. The authors of the study wrote that, the variants B.1.1.7 and B.1.351 were "predominant" strains in the country.

The results showed that the Pfizer vaccine was87 to 89.5% effective effective to prevent infection by B.1.1.7 two weeks after the administration of their second dose. Researchers have also seen promising results for B.1.351, noting that the vaccine was 72.1% to 75% effective in preventing infection two weeks after the second dose,The temperature reports. And for more information on the last search on vaccination,The Pfizer vaccine protects you at least this long study discovery.

The second set of new research, which was originally published in the medical newspaperThe lancetComes from a joint study conducted by the Ministry of Health and Pfizer of Israel. The team analyzed more than 230,000 COVID-19 cases reported in the country from January 24 to April 3 to find that theB.1.1.7 "U.K. Variant" was responsible for about 95% of all cases at the time. About 50% of the country's population was also vaccinated during this period,The temperature reports.

The study revealed that the vaccine against Pfizer was96.5% effective In infection protection, 98% against hospitalization and 98.1% against death 14 days after the second dose, and even maintained 94% efficiency for those aged 85 and over. However, the authors emphasized that those with a single dose have seen much less protection, noting that a single 57.7% protection against infection, 75.7% against hospitalization and 77% against the dead.

While the two studies offered a lot of reassurance from the high efficiency of the vaccine, an expert emphasized that it also highlights the importance ofreceive the two shots Be completely protected. Disease control and prevention centers (CDC) data have recently shown that millions of people have missed or not returned for theirFollow-up injections.

"This really highlights strongly, with variants, who need the second dose," "Kathleen Neuzil, MD, Director of the Vaccine Development Center at the University of Medicine of Medicine at the University of Maryland, saidThe Washington Post. "What is a message we deliver, but we now have human clinical data to support this message." And for more potential boosters,That's when you need a third covider, "said Biontech CEO.